FAQ

Built multiple sets of modular, multi-functional intelligent dr‍ug automatic synthesis platform

The company's main business is the research aεnd development and sales of drug synthesis systems

The company's main business is the research and sales of drug synthesis system¶s. It has built multiple modular and multifunction₹al intelligent drug fully automatic synthesis platforms, which can efficiently and stably complete €the high-throughput preparation of drugs with different synthesis paths and meet st♥rict clinical quality control requirements.

Developed various new nuclide labeled positron emissio‍n tomography tracers

We have developed a variety of new nuclide labeled positron emission tomograph£y tracers (such as 18F-Safranamide, 18F-FHBG, 18F-MK9470, etc.) with high applica tion value in the mechanism research and diagnosis of major diseases such as tum≥ors, cardiovascular and cerebrovascular diseases, and neurodegenerati←on.

Brand value gradually forms an impact in the field of medical i maging

Hangzhou Jirui Technology Co., Ltd., established in September 2018, is a small and micro enteδrprise with brand value gradually forming an impact in the field of medical imaging. The com∞pany's main business is the research and development and sales of drugφ synthesis systems